CURRICULUM VITAE
DATO DR. NOR SHAHIDAH KHAIRULLAH DPMP JMN
MB,BS, MSc, FRCPath, FAMM, WOSAAM, AAAM
1
CURRICULUM VITAE
Dato’ Dr Nor Shahidah bt. Khairullah MB,BS ( Mal) , FRCPath (UK), MSc (Lon), FAMM
(Mal), AAAM (USA), WOSAAM (EuR),
TERTIARY EDUCATION AND QUALIFICATIONS
1978-1983
:
University of Malaya, Faculty of Medicine
Bachelor of Medicine, Bachelor of Surgery (MB,BS)
1987-1988
:
University of London, London School of Hygiene and Tropical
Medicine
Master in Science in Clinical Virology (MSc.)
1994
:
Membership of Royal College of Pathologists
United Kingdom (MRCPath)
1997
:
Member of Academy of Medicine Malaysia (AM)
2002
:
Fellow of Academy of Medicine of Medicine Malaysia (FAMM)
2003
:
Fellow of the Royal College of Pathologists
United Kingdom (FRCPath)
2009
:
Board Certification American Association Aesthetic Medicine
(AAAM)
2009
:
Board Certification World Society AntiAging Medicine
( WOSAAM Europe)
2007
:
Datuk Paduka Mahkota Perak (DPMP)
2006
:
Johan Mangku Negara (JMN)
1993-1994
:
Petronas Subspecialty Award in London United Kingdom
1990
:
British High Commissioner’s Research Award in Oxford United
Kingdom
AWARDS
2
WORK EXPERIENCE
Current Appointments
July 2013
present :
Corporate Director Of Medical Affairs , Villa Medica
International. ( Regenerative Medicine )
January 1999- present : Chief Executive Officer & Medical Director,
Molecular Research Laboratory, Malaysian Liver Foundation ( Voluntary)
Past Appointments
Corporate
August 2010 –June 2013
:
April 2008 – June 2013
:
May 2008-April 2012 :
Bhd
Consultant Physician , Global Doctors Specialist
Hospital
Medical Adviser, Ruyi Holdings Sdn Bhd
External Medical adviser Sanofi Aventis (M) Sdn
January 1999- December 2000 : Asia Pacific Infectious Disease Clinical Research
Physician For Eli Lilly Pharmaceuticals & Co Asia
Pacific
May 1999- December 2000 :
External Medical Consultant for Hepatitis and HIV
GlaxoWellcome Pharmaceuticals (M) Sdn Bhd
April 1998- January 1999 :
Medical Director for Malaysia and Singapore
Eli Lilly (M) Sdn. Bhd and Eli Lilly Singapore Pte
Ltd
Mar 1997 – 1998
:
Assoc. Medical Director
Specialty Medical Laboratories Sdn Bhd
Academic
January 2013- Jun 2013
:
Deputy Vice Chancellor , Research & Innovation ,
MAHSA University
September 2012 – December 2012 : Dean for Centre for Post Graduate Studies ,
MAHSA University
1988-February 1997
:
Associate Professor/Consultant Virologist
Department of Medical Microbiology
Faculty of Medicine, University of Malaya
3
Overseas appointments
1994
:
Senior Registrar/Consultant
Heartland Hospital, Birmingham B9 5SS
United Kingdom
1993
:
Senior Registrar/ Consultant
Department of Virology
Royal Free Hospital, United Kingdom
PROFFESSIONAL COMMITTEES
1.
Scientific Advisory Committee, Drugs for Neglected Diseases Initiative
(DNDi Geneva) ( 2005-2012)
2.
National Credentialling and Privileging Committee for Aesthetic Medical
Practices Ministry of Health (2010-present)
3.
National Subcommittee on Education and Training for Aesthetic Medical
Practices Ministry of Health ( 2012-present)
4.
Board member Society of Advancement of Hormones and Healthy aging
Malaysia (SAHAAM) (2009 - 2012)
5.
Board member Malaysian Society for Aesthetic Medicine (MSAM) (2010present)
6.
Board member Malaysian Astrological society (MAS) (2009-2012)
7.
National Formulary ‘Blue Book “ Committee (2003-2009)
8.
National Committee for Research & Development in Herbal Medicine
(2002- 2009)
9.
Beta Group for Integrated Global Hub in Traditional and Complementary
Medicine (2003- 2009)
10. National Scientific and Ethics Committee for Ministry of Health Malaysia
(2001-2010)
11. Genetic Modification Advisory Council Malaysia (2003-2011)
12. National Committee for Vector Borne Diseases ( 2001- 2010)
13. ASIAN Regional Coordinator for Global R&D Coalition for TB Research
(2001- present)
14.
National Food Safety Committee ( 2002 - 2009)
4
15.
National Committee on Good Laboratory Practice (2001- 2009)
16. Chairman, Infection Control Committee, Ministry Of Health Malaysia (20022004)
17. National Committee for Clinical Research Ministry of Health, Malaysia
(1999-2010)
18. Steering Committee for the prevention and control of infectious diseases in
the Asia Pacific (2001-2009)
19. National Committee on Good Clinical Practice, Ministry of Health Malaysia
(1998-2008)
20. Suitability of Hepatitis A vaccines, HAVRIX Paediatric 360 and HAVRIX
1440
for registration in Malaysia : 12th April 1996
21. Ministry of Health, Malaysia Issues in the control of Influenza in Malaysia :
6th December 1995
22. World Health Organisation, Geneva, Switzerland; Global Surveillance of
Respiratory viruses-Current status : 25-27th March 1992
23. Ministry of Health, Malaysia; Certification of Polio virus vaccine in Malaysia
: 15th June 1992
24.
Main Advisory Committee (MAC) University Hospital : 1995-1997
25. Coordinator for WHO Collaborating Centre for the surveillance, diagnosis
and control of Influenza in Malaysia (1989-1996)
RESEARCH EXPERIENCE
1) International Clinical Trials

A double-blind parallel group, placebo controlled, multi-centre, phase III
A study to assess the safety and efficacy of oral famciclovir (three times a
day) for the treatment of chronic hepatitis B in an Asian Population
(1996-1998)

A double-blind, double dummy, randomised, multicentre Acyclovircontrolled, parallel group study to compare the safety and efficacy of
Famciclovir and Acyclovir in treatment of patients with uncomplicated
Herpes Zoster (1995-1996)
5

An open study to determine the efficacy of Lamivudine on HBV DNA
clearance and to assess the safety of the regimen in Asian patients with
chronic hepatitis B infection (1998-1999)

An open label study assessing the efficacy and safety of different
formulations of cefaclor in the treatment secondary bacterial infections in
acute and chronic bronchitis among patients in the Asia Pacific region
(1999-2000)

A randomized double blind placebo controlled study of oral Lobucavir in
subjects chronically infected with hepatitis B virus who have failed or are
intolerant to alpha-interferon therapy (1998-2000)

A double blind placebo controlled clinical endpoints trial of Lamivudine
in patients with hepatitis B related cirrhosis (1998-2003)

A randomized double blind placebo controlled study of Adefovir Dipivoxil
for the treatment of patients with HBeAg positive CHB infection (19992001)

A phase 11 study of the safety and antiviral activity of Entecavir (BMS200475) vs Lamivudine in adults with CHB (1992-2000)

A phase 11 study comparing the safety and antiviral activity of
Therapeutic Hepatitis B vaccine (Pharmacine) plus Lamivudine vs
Lamivudine alone in adults with CHB (2000-2002)
2) Basic Research

Innovative approaches for diagnosis and management of dengue virus
infections

Molecular characterization of a Malaysian Nipah virus isolate

Research & Development and production of viral infectious clones with
special emphasis on SARS coronavirus, dengue virus and hepatitis C virus

Seroepidemiology study of MMR in Malaysia

Incidence and molecular epidemiology of Japanese Encephalitis (JE) In
Malaysia

To study the clinical and virological prognostic factors of different
enteroviruses involved in HFMD in Malaysia

The use of recombinant proteins and synthetic peptides for diagnosis and
the elucidation of virulence markers in dengue virus infection
6


Rapid diagnosis of Human cytomegalovirus in the management of
immunocompromised patients.

Characterisation of Malaysian Dengue Viruses

Development of rapid diagnosis for cytomegalovirus

Development and evaluation of rapid diagnostic methods for detection of
respiratory viruses
Technical and Experimental Skills
Traditional Culture and Detection Methods
Viral cell culture, Plaque assays, Neutralisation assay, Enzyme linked
Immunosorbent Assay (ELISAs), Flourescent antibody assays, Haemagglutination
assays,
Complement Fixation assay,
Electron microscopy
Molecular Biology ( Nucleic acids and proteins )
RNA and DNA extraction methods, Southern, Northern and Western Blotting using
radioactive and non radioactive labels,
Polymerase Chain Reaction, Branched Chain DNA cDNA synthesis,
DNA and RNA sequencing,
Baculovirus expression and Vaccinia virus expression of viral genes, Radioimmunoprecipitation, Synthetic peptide synthesis (FMOC), Restriction Enzyme
analysis, In situ hybridisation assay, Real time PCR.
3. Supervisory Experience
a) Masters of Medical Science
1. Expression of a Carboxy-Terminally truncated envelope protein of a
Malaysian dengue-3 virus in insect cells by a recombinant baculovirus
(1995-1997)
2. Molecular Characterisation of Malaysian dengue viruses (1996-1999)
3. Molecular Characterisation of Malaysian dengue 3-viruses (1996 – 1999)
b) Master of Pathology - Virology

An evaluation of a commercial dengue Ig M capture ELISA
kit(1995-1996)
7
c)
Diploma of Advanced Certificate in Medical Laboratory Technology
a) The use of shell vial assay in the isolation of viruses in clinical specimens
(1992)
b) Comparative evaluation of two methods for the diagnosis of Rotavirus
infection (1992)
c) Dot immunobinding assay for the diagnosis of Japanese Encephalitis
infection in Malaysia (1991)
d) BSc. Biomedical Science
Comparative evaluation of two primers in the diagnosis of Human
cytomegalovirus using the polymerase chain reaction (1996)
c) BSc. (Hons) Biochemistry
The role of HCMV as a risk factor in the development of atherosclerosis in
a selected Population (1996)
B.
Workshops Organised
1) Liver Update Meetings since 1997 till todate
2) Good Clinical Practice (GCP) - an introduction 1998
3) The Application of Amplification Methods in Viral Hepatitis 2000
4) Mentoring Workshop 2013
C.
Evaluation Activities
University Level
Examiner for the following thesis :




Master of Philosophy ( PhD)
Masters of Medical Science
Diploma of Advanced Certificate in Medical Laboratory Technology
Evaluation of research proposals submitted for postgraduates
degrees
8
Master of Medical Science
PhD
a)
Molecular and Cellular Biology of Dengue virus
1995
b)
Molecular Biology of Dengue viruses
1995
c)
Molecular Immunology of Dengue viruses
d)
Molecular Characterisation of Helicobacter pylori strains
a)
b)
Molecular Studies of Rickettsial Infections
Molecular characterization of Nipah Viruses
1995
1995
1995
2002
Editorial Work
1) Editor- Liver News
1998 - present
Official Newsletter of The Malaysian Liver Foundation (3 issues a year)
2) Editor : Journal of the Malaysian Astrological Society (2009- present )
3) Editor- Infection and Chemotherapy
1997- 2000
Official Newsletter of The Malaysian Society of Infectious Diseases And
Chemotherapy
3) Reviewer- MIMS MEDEX 1998 (Malaysia)
Manuscript entitled : Designing Pathology Laboratories
4) Editor - Journal of University Malaya Medical Centre (JUMMEC)
(1996-1997)
5) International Reviewer - Journal of Medical Virology (1995)
Manuscript entitled :
Detection of dengue-2 sense, antisense,
replicative intermediate and replicative form
RNA in Aedes psuedoscutellaris (AP 61) and
baby hampster kidney (BHK-21) cells
6) Reviewer - Journal of Tropical Biomedicine (1990)
Manuscript entitled :
Experimental infection of Macaca fascicularis
and Presbytis cristada with SA11 Group A
Rotavirus
9
D.
Past Administrative Duties
a)
University level


b)
Fellow of 3rd Residential College, University of Malaya
Coordinator for Virus positive reports sent monthly to centres within
Malaysia and Western Pacific Basin
Faculty
1. Internal examiner for the following courses:
Master of Pathology
Stage 2 MB,BS (Medical)
Year 2 BDS (Dental)
School of Nursing-Both the basic and the advance course
Year 3 and Biomedical Sciences
Bachelor of Science (Hons) Pharmacy
Diploma in Advanced Certificate in Medical Laboratory Technology
Coordinator for Virology Examination (Theory and Practical) for the above
courses
2. Pioneer member of Editorial Board of Faculty of Medicine’s Journal
(JUMMEC)
3.
Member of the Main Advisory Committee (MAC) of the University Hospital
4.
Post graduate (research) Ad-hoc committee
5.
Coordinator for the Medical Microbiology course for the Department of
Pharmacy
c)
Department
1.
2.
Curriculum subcommittee
Translation of examination questions into Bahasa Malaysia and advocating
the use of Bahasa Malaysia in the Medical and Dental teaching
SPEAKING ENGAGEMENTS

“Healthy Aging and Beauty from the Inside Out “ : Conference of the Indonesian
Society of Reversing Aging Society ( July 2012)

Implications of the the Sixth House in Vedic Astrology : International Conference
in Astrology and Vasthu , Kathmandu, Nepal ( August 2012)

Hepatitis Vaccines . Liver Update 2011
10

Conference of the Indonesian Society of Reversing Aging Society ( July 2011)

Singapore General Practitioners Society Meeting (2010)

Conference of the Indonesian Society of Reversing Aging Society ( July 2010)

Herbal Medicine Research – Issues and Challenges. Nuetraceuticals,
Complementary Medicine & Wellness Asia 2003 Summit. (August 2003)

Herbal Hepatoxicity- Liver Update 2003

Viral Infections in liver transplant patients –Liver Update 2003

SARS diagnosis in Malaysia -experience of the SARS Reference Laboratory.Mid
year seminar of the Malaysian Society of Parasitology and Tropical Medicine
(July 2003)

Clinical Research In Malaysia- GCP workshop, International Medical University
(July 2003)

Good Laboratory Practice and Good Clinical Practice .GCP workshop , Ministry of
Health Malaysia ( July 2003)

Vaccination- Current situation and perspectives. 13th MIMLS National Scientific
Conference ( September 2002)

Hepatitis A outbreaks- a role for immunization. Ministry of Health (April 2002)

Hepatitis Management Programmes in Malaysia. International Congress on
Infectious Diseases Singapore ( March 2002)

Hepatitis A in Malaysia. Asia Pacific Steering Committee for the Prevention Of
Infectious Diseases, Singapore (November 2001)

Hepatitis A epidemiology in the ASEAN region. Evidence-based Vaccinology ,A
Regional Conference ,Kuala Lumpur (June 2001)

GCP and Laboratories- Workshop in Clinical Trials Methodology HUKM (October
2001)

Viral Hepatitis in the ASEAN region . First Asia Pacific Congress of Medical
Sciences, Kota Bharu (May 2001)

Utility of hepatitis virus nucleic acid based diagnostics in therapeutic drug
trials.11th Scientific Meeting of the Malaysian Society of Molecular Biology and
Biotechnology (May 2001)

Epidemiology and Disease Burden of Viral Hepatitis in Malaysia . National
Hepatitis Symposium (November 2000)
11

.

Utility of Viral Load Testing in Management of Chronic Viral Hepatitis. National
Hepatitis Symposium (November 2000)
Introduction to ISO 17025 Laboratory Accreditation System. 1st National
Symposium in Good Laboratory Practice (November 2000)

GLP in Molecular Biology -1st National Symposium in Good Laboratory Practice
(November 2000)

Principles of ICH GCP- 35th Malaysia –Singapore Congress of Medicine (August
2000)

Malaysian Guidelines on GCP-35th Malaysia –Singapore Congress of Medicine
(August 2000)

Malaysian Guidelines On Good Clinical Practice- Workshop in Clinical Trials
Methodology HUKM ( September 2000)

GCP and Laboratories- Workshop in Clinical Trials Methodology HUKM
(September 2000)

Malaysian Guidelines On Good Clinical Practice – National Workshop in Good
Clinical Practice ( August 2000)

Cefaclor in the Millenium- Lilly Lecture Symposium, Bangkok, Thailand ( August
2000)

Vancomycin –An update. The treatment of pneumonia among intravenous drug
abusers –a symposium. Army Hospital,Soebroto, Jakarta, Indonesia ( October
1999)

New Antivirals – Infectious disease symposium
33rd Malaysia- Singapore Congress of Medicine ( 1999 )

Management of Chronic Hepatitis B –an update
Lecture series coorganised by The Malaysian Liver Foundation and MMA (19982000)

Management Of Chronic Hepatitis – Update on Antivirals
Weekend Tutorial in Hepatitis For GPs- Malaysian Liver Foundation (1998)


Epidemiology of Hepatitis B and C and the Link to Hepatocellular Carcinoma
Consensus Guidelines on Screening For Hepatocellular Carcinoma, Academy of
Medicine and Malaysian Society Of Gastroenterology and Hepatology
(October 1998)
Diagnosis of Viral Infections-Techniques and Clinical Utility
Annual Scientific Meeting of The College Of Physicians Malaysia (May 1998)
12

Polymerase Chain Reaction
National Workshop in Clinical & Epidemiological Research Methods Ministry of
Health Malaysia (November 1997)

8th National Scientific Conference Of The Malaysian Institute Of Medical
Laboratory Sciences (October 1997)
1.Diagnosis Of Mycobacterial Infection: An Update
2.Utility Of Amplification Techniques In Viral Hepatitis

31st Malaysia-Singapore Congress Of Medicine (1997)
Universal Precautions Against HIV For The Paediatricians. Techniques And Cost
Benefits

Malaysian Society Of Infectious Disease And Chemotherapy and Ministry of
Health (1997)
Laboratory Diagnosis Of Viral Infections - Public Forum

Malaysian Society Of Infectious Disease And Chemotherapy and Dewan
Bandaraya (1997) - Public Forum on Viral Gastroenteritis

Malaysian Society Of Infectious Disease And Chemotherapy (1996) - Scientific
Meeting Respiratory Syncytial Virus

Hospital Kuala Lumpur (1996)
Preparatory Course For MRCP Part 1-Infectious Diseases

Petronas Training Centre, Malacca (1995)
Hepatitis A Vaccination

19th Annual Scientific Meeting Of The Malaysia Society Of Health (1995)
Immunisation In The Prevention Of Virus Associated Cancer

SEAMEO-TROPMED; Diploma In Medical Microbiology (1989-1992)

University Kebangsaan Malaysia (1990)
Antiviral Chemotherapy - Weekend Course In Infectious Diseases
Media Personality (RTM 1)

Selamat Pagi Malaysia (1997)
Topics : Hepatitis
Diarrhoea
Obesity
Insomnia
Rash
Coughs & Colds
13
ORGANISING COMMITTEES
Regional and Local Congresses

First Malaysia –Singapore Congress of Aesthetic Medicine (2012)

Liver Update (2011)

First Islamic (OIC) Conference of Ministers of Health (2007)

Second Annual Conference “Self Reliance Programme in Vaccines Among OIC
Countries” (2005)

6 Liver Update International Conference (2005)

5 Asia Pacific Travel Health Conference (2004)

International Conference in Traditional and Complementary Medicine (2003)

Liver Update ( 2002-2003)

4th Asia Pacific Conference in Travel Health (2002)

6th International Forum on Global Vaccinology ( 2002-2003)

First National Life Sciences Conference- Genomics and Health ( May 2002)

Evidence-based Vaccinology Symposium (June 2001)

Asia Pacific Clinical Trial Conference (2000-2001)

National Symposium on Good Laboratory Practice (2000)

National Hepatitis Symposium (2000)

Liver Update 2001 (2000-2001)

Liver Update 99 (1998-1999)

33rd Malaysia-Singapore Congress of Medicine (1998 - 1999)

Liver Update 97 (1996-1997)

6th Western Pacific Congress of Infectious Disease and Chemotherapy
WESPAC:(1995-1998)

University of Malaya Women’s Association : Seminar on Women and Health
(1991)
14

7th International meeting of the International Union of Venereal Diseases and
Treponematoses (1990)
MEMBERSHIP IN ACADEMIC AND PROFESSIONAL ASSOCIATIONS
1)
i.
ii.
iii.
iv.
v.
vi.
vi.
vii.
Past
Academic Staff Association of the University of Malaya
Alumni of the University of Malaya
Academic Staff Association of Faculty of Medicine - Treasurer
Malaysian Association of Private Medical Laboratories - Vice President
Malaysian Society of Molecular and Cellular Biology
Malaysian Society of Infectious Disease and Chemotherapy ( 1998- 2000)
Committee member
Pacific Basin Respiratory Virus Research Group - Editorial Board member
American Society for the Advancement of Science
2)
Present
i.
Malaysian Liver Foundation (1997-) Research Chairman and Scientific
Advisory
Committee
iii.
Malaysian Society of Travel Medicine ( President 2002 - 2004)
iv
Asia Pacific Travel Health Society (2003- 2006)– President
SUBMITTED VARIOUS PUBLICATIONS AND RESEARCH REPORTS
PUBLICATIONS
1.
Fuxun Yu, Nor Shahidah Khairullah et al.
(2006).Serodiagnosis using recombinant Nipah Virus
nucleocapsid protein expressed in E coli .J Clin Microb; 44 (9)
:3134-3138
2.
Nor Shahidah Khairullah, Ismail Merican.Chronic Hepatitis B
and Herbal Therapy. Medical J Malaysia (2005); Suppl B:35-38
3.
Nor Shahidah Khairullah .Hepatitis A vaccines Medical J
Malaysia (2005); Suppl B:112-15
4.
Nor Shahidah Khairullah, Ismail Merican.Hepatitis
Management Programmes in Malaysia .J Gastroenterol Hepatol
2004;19 Suppl :S13-16
5.
TS Saraswathy,Nor Shahidah Khairullah et
al.(2004)Laboratory Acute Flaccid Paralysis Surveillance in
Malaysia: A decade of Commitment to the WHO Global Polio
Eradication Initiative.Southeast Asian J Trop Med Public
Health:35(2):421-424
15
6.
Nor Shahidah ,Ismail Merican and Raman Ismail
(2003).Influenza Surveillance in Malaysia :1997-2001.Malysian
J Public Health Medicine;3(1):11-15
7.
Nor Shahidah Khairullah. Herbal Hepatotoxicity Medical J
Malaysia (2003) 58; Supple B: 66-74
8.
A Padmanathan, NS Khairullah and I Merican . Determination
of HBV Polymerase Gene Mutations in Chronic hepatitis B
Patients Medical J Malaysia(2003) 58; Supple B: 84
9.
Y Roziyah, NS Khairullah and I Merican (2003). Distribution of
Hepatitis C genotypes in Malaysia. Medical J Malaysia ; Suppl
B:108
10.
Nor Shahidah Khairullah. Other viral infections in liver
transplant patients.Medical J Malaysia (2003) Med J Malaysia
58; Suppl B:77
11.
A Padmanathan ,NS Khairullah and I Merican .Prevalence of
hepatitis B Genotypes in Malaysia (2003) Medical J Malaysia;
58 Supple B: 83
12.
N Khairullah and I Merican et al. (2002)Age specific
seroprevalence of hepatitis A virus infection in Malaysia- a
changing pattern. Asian-Oceanian J Paediatrics & Child
Health;1 (2):137-145
13.
Nor Shahidah Khairullah. Travel Medicine in Malaysia- a
Country Report. 4th AsiaPacific Travel Health Conference
(2002):119
14.
NS Khairullah, V Subramaniam, LK The,N Shamsiah. Nipah
virus Encephalitis.4th AsiaPacific Travel Health Conference
(2002):115
15.
Nor Shahidah Khairullah.Vaccination, Current Situation and
Perspective.13th National Scientific Conference of the
Malaysian Institute of Medical Laboratory Sciences(2002):19
16.
LY Lim,Vijayamalar B, NS Khairullah. Laboratory Diagnosis of
HIV in Infants.5th Scientific Meeting of the Institutes of Health ,
Ministry of Health Malaysia(2002):49
17.
R Thayan, F Sonkerim, V Subramaniam ,NS Khairullah.
Virological Surveillance of Dengue Serotypes. 5th Scientific
Meeting of the Institutes of Health , Ministry of Health
Malaysia(2002):50
16
18.
TS Saraswathy,NS Khairullah,F kassim,MA Yusof,MS Mohd
Zain.Laboratory AFP Surveillance in Malaysia:A decade of
commitment to the WHO Global Polio Eradication Programme.
5th Scientific Meeting of the Institutes of Health , Ministry of
Health Malaysia(2002):47
19.
NS Khairullah et al. Dengue virus infection in Malaysia.
International Congress of Infectious Diseases, Singapore
(2002):32
20.
V Balasubramaniam, NS Khairullah et al. Persistance of Nipah
virus IgG and IgM in asymptomatic and post nipah encephalitis
patients. International Congress of Infectious Diseases,
Singapore ( 2002):87
21.
CC Roa, NS Khairullah and PA Punzal et al. The Clinical
Efficacy of Cefaclor in the Treatment of Secondary Bacterial
Infection in Bronchitis.(2001).Supplement to Medical
Progress:28:5:5-12
22.
Nor Shahidah Khairullah. Viral Load Assays
(2001).Supplement to Medical Progress.:28:7;101-104
23.
A.Pathmanathan, NS Khairullah ,I Merican. Validation of the
ICT Rapid Assay for the dual Detection of Hepatitis B Surface
and HBeAg (2001).Liver Update 2001”Lessons from the
Past,issues for the Future”;9-15 July:36
24.
Roziyah Yusup, Nor Shahidah Khairullah, Ahila
Pathmanathan, Ismail Merican (2001).Hepatitis C virus
genotypes in Malaysia.Supplement to Medical
Progress,28:7:121-123
25.
Ahila Pathmanathan,Nor Shahidah Khairullah,Ismail
Merican(2001). Seroprevalence of HBsAg and HBsAb among
children in Johore. Supplement to Medical Progress:28:7:124127
26.
Nor Shahidah Khairullah (2001). Utility of hepatitis virus
nucleic acid based diagnostics in therapeutic drug trials.11th
Scientific Meeting of the Malaysian Society of Molecular
Biology and Biotechnology ;pg 15
27.
Nor Shahidah Khairullah (2000). Principles of ICH GCP 3rd
Ministry of Health- Academy of Medicine Scientific Meeting ;
pg 57
28.
Nor Shahidah Khairullah (2000). Malaysian Guidelines on
Good Clinical Practice 3rd Ministry of Health-Academy of
Medicine Scientific Meeting ; pg 60
17
29.
Roziyah Yusup, Nor Shahidah Khairullah,Yasmin Othman and
Rohana Yusof (1999) Comparison of Nucleotide Acid
Sequences of the 3’ Noncoding Region of Malaysian Dengue-3
viruses .11th National Biotechnology Seminar , 22-24
November: 268-269
30.
HM Cheng and NS Khairullah (1998) : CMV Infection and
antiphospholipid antibody production. Clinical Infectious
Diseases
31.
YF Ngeow, AF Weil, NS Khairullah, MY Mohd Yusof, L Lam, C
Gaydos and TC Quinn (1997)Young Malaysian Children with
Lower Respiratory Tract Infections Show Low Incidence Of
Chlamydial Infection. J.Paediatr. Child Health ; 33:422-425
32.
HM Cheng and NS Khairullah (1997) : Hepatic virus and
antiphospholipid antibodies .Hepatology : 25(3) : 781-782
33.
NS Khairullah, CK Wong and CK Koh (1996) : Prevalence of
varicella-zoster virus antibodies in the University Hospital,
Kuala Lumpur : WESPAC 1998 :184
34.
NS Khairullah, PS Hooi, LL Chan and CT Chua (1996) : The
diagnosis of human cytomegalovirus infections in the
University Hospital, Kuala Lumpur. The Malaysian Journal of
Medical Laboratory Sciences. 13(i) : 15-17
35.
MY Fong, NS Khairullah and N. Ariffin (1996) : Detection of
human cytomegalovirus in human leucocytes by polymerase
reaction : an evaluation of two primers. The Malaysian Journal
of Medical Laboratory Sciences. 13(i) : 15-17
36.
KB Chua, NS Khairullah et al. (1996) : Infectious
mononucleosis-like syndrome - a report of 5 cases. The
Medical Journal of Malaysia
37.
EH Boxall and NS Khairullah (1996) : Spectrum of persistence
of anti HBc lgM antibodies in acute hepatitis B 1X Triennial
International Symposium on Viral Hepatitis and Liver Disease,
Rome Italy : 135
38.
KB Chua, NS Khairullah and PS hooi (1996) :
Seroepidemiology of human herpesvirus 6 in a population seen
in the University Hospital, Kuala Lumpur, Malaysia. Southeast
Journal of Tropical Medicine and Public Health; 27 : 1: 91-95
39.
NS Khairullah (1996): Comparison of two monoclonal
antibody kits with cell culture isolation in the detection of
respiratory virus antigens. Malaysian Journal of Pathology; 18
(1) : 27-30
18
40.
Chong SS, Khairullah NS, Koh CL (1995): Expression of a
Carboxy-terminally truncated protein of dengue 3 virus in
insect cells by a recombinant Baculovirus. Proceedings of the
7th National Biotechnology Seminar : 124-126
41.
NS Khairullah and SK Lam (1995): Evaluation of WHO
monoclonal antibody kits for diagnosis of acute respiratory
viral infection. Southeast Journal of Tropical Medicine and
Public Health : 26:2:263-267
42.
NS Khairullah, KB Chua, CA Razali and PS Hooi (1995) :
Comparative Evaluation of two monoclonal antibody kits for
the detection and typing of respiratory viruses. Progress in
Clinical Virology Joint meeting of European Group for Rapid
Viral Diagnosis: 245
43.
CA Razali, PS Hooi and NS Khairullah (1995): Comparison
between standard tube and shell vial assay for the isolation of
viruses in clinical specimens. 6th ASEAN Conference in
Medical Laboratory Technology : 124
44.
NS Khairullah (1995) : Respiratory Virus Surveillance in
Malaysia. Pacific Basin Respiratory Virus Research Group
Newsletter Vol 3 No 1 : 6
45.
NS Khairullah, EH Boxall, JA Shirley (1994) : Rapid
Dissappearance of anti-HBc IgM in patients with acute
hepatitis B infection. Progress in Clinical Virology : Joint
Meeting of European Group for Rapid Viral Diagnosis and
Encephalitis group : 109
46.
NS Khairullah (1994) “ Respiratory virus in Malaysia. Pacific
Basin Respiratory Virus Research Group Newsletter Vol 2 No1
:5
47.
M Grandien, NS Khairullah and CR Madeley (1992) : Use of
monoclonal antobodies for rapid diagnosis of respiratory
viruses. Bulletin of the WHO; 70(60) : 699-70
48.
MY Yusoff, NS Khairullah, PS Hooi (1992), Serological
diagnosis of Mycoplasma pnuemonia respiratory tract
infection in the University Hospital. Silver Jubilee Celebrations
of the University Hospital.
49.
TS Soo-Hoo, NS Khairullah, KP Ng (1992) : Infections in
immunocompromised patients. Silver Jubilee Celebrations of
the University Hospital.
50.
NS Khairullah (1991) : Baculovirus Expression of Dengue -3
virus envelope protein, Annual report from WHO Collaborating
19
Centre For Arbovirus Reference and Research (Dengue and
Dengue Haemorrhagic Fever); 10-11
51.
NS Khairullah and PR Young (1990): Immunoblot and
enzyme immunoassay analysis of human antibody responses
to dengue infections. Proceedings of the 3rd National Biology
Seminar and the First Scientific meeting of the Malaysian
Society of Molecular and Cellular Biology : 3-4.
52.
NS Khairullah, CM Teoh, SC Ng, GE Kua (1990) : Prevalence of
cytomegalovirus antibodies in University Hospital Blood
Donors. Tropical Biomedicine ;7: 125-127
53.
NS Khairullah. Influenza surveillance in Malaysia (1990).
Weekly Epidemiology Report, WHO Geneva : 4(2) : 248
54.
NS Khairullah (1990) : Cytomegalovirus and Bone Marrow
transplantation. Medical Microbiology Bulletin
55.
NS Khairullah and PR Young (1989): Human antibody
responses to dengue virus infections 14th Annual and
General Scientific. Meeting of the Malaysian Society of
Pathologists; 19
56.
NS Khairullah (1989) Working Towards Prevention of
Diarrhoeal Diseases in Malaysia. WHO programme for Control
of Diarrhoel Diseases
57.
S Devi and NS Khairullah (1988) : Diagnosis of Japanese
encephalitis by IgM capture assay. 25th Silver Jubilee
Celebrations of the Faculty of Medicine, University Malaya.
58.
NS Khairullah, Z Manaf and YF Ngeow (1986) : Comparative
Evaluation of two methods for the serological diagnosis of
Chlamydia trachnomatic infection. Malaysian Journal of
Pathology : 8:71-74
59.
NS Khairullah, SK Lam, CH Lee (1986) : Evaluation of Herpes
Simplex reagents. Exchange Newsletter for Southeast Asia and
Western Pacific Region : 2(4).
Research Reports
1)
NS Khairullah. Regional Report from Southeast Asia and Western Pacific
Region on the usefulness of a WHO monoclonal antibody kit for the diagnosis
of respiratory viruses. WHO, Geneva, Switzerland : 25-27th March 1992.
2)
NS Khairullah. Humoral responses to dengue virus proteins in patients with
dengue and dengue haemorrhagic fever. Thesis submitted for part
20
fulfillment of the degree of Master of Science in Virology; London School of
Hygiene and Tropical Medicine : 1988.
CORPORATE PAST APPOINTMENTS
JOB DESCRIPTION
1. MEDICAL DIRECTOR, ELI LILLY Malaysia Sdn Bhd & Singapore Pte Ltd (
April 1998-January 1999)
Malaysian Operations
1. Clinical Trials
a. Responsible for the overall planning, execution and reporting of clinical trial
in line with
affiliate objectives
b. Establishment of letter of agreements generic to local and regional trials
c. Establishment of the safety and efficacy of new drugs by excercising
pharmacovigilance
2. Quality System Implementation
a. Establish policies and procedures for the implementation, pertaining to
approval of medical information (clinical papers) and all forms of
promotional materials in both hard or electronic copy for Sales and
Marketing
b. Provide appropriate medical input into patient information leaflets, launch
letters for commercialisation
3. Customer Relations
a. Set up Advisory/Focus groups comprising of Key Opinion Leaders for
therapuetic areas
to foster ties and develop confidence for strategic marketing
b. Assist in conducting marketing research
c. Facilitate round table discussions twice a year during Advisory/Focus group
meetings
d. Participate in Committees/Organising Committees in Professional
associations / scientific Meeting respectively to strenghten customer
relationship and create presence
e. Organise and coordinate appropriate scientific sessions for Annual
Symposium for CME accreditation
21
4. Sales and Marketing Support
a. Conduct at least two clinical training sessions a month for Sales and
Marketing staff in Malaysia and Singapore
b. Review clinical papers with Marketing personnel as and when required
c. Assist and advice in activities for clinical lifeplan of products and launching of
new products
5. Regulatory
a. Develop good relationship with Key Government Regulatory Personnel
b. Ensure timely submission of Registration Dossiers in line with Affiliate
strategy
Regional Operations
a. Act as Overall Medical Regional Advisor for Infectious Diseases portfolio for
Lilly Asia Pacific
b. Advisory, supervision and Sign off and Approval of Clinical Trials Protocol
and Clinical Report Forms
c. Analysis ,Report and Control of Adverse Events For Clinical trials,
spontaneous and post marketing
d. Consultant Support to Regional Infectious Disease Marketing Manager
e. Drive the formation of Regional Advisory Board
f. Drive Medical Response Defence to competitor marketing attack
g. Advisory on Medical Content of IT program for Marketing
2.
MEDICAL DIRECTOR, SPECIALTY MEDICAL LABORATORY (1997-1998)
Laboratory Operations

Consults in the development of new procedures for ultimate transfer to
clinical laboratory and approve the release of new testing procedures.

Consults with the appropriate technical staff to ensure appropriate quality
control parameters, policies and procedures and related documentation are
developed.

Consults with key individuals to plan test development strategies. Examines
potential marketability of tests, consults the technical personnel to evaluate
resource requirements.

Directs the maintenance of all required data documenting the development
of each procedure transferred to the clinical laboratory and establish ongoing monitoring efforts. Directs technical staff in the trouble-shooting of
22
problematic assays in Clinical Laboratory. Works with the appropriate
Technical staff to provide lasting solutions to identified problems.

Evaluates the potential for implementing of improvements in existing clinical
procedures as suggested by technical staff.

Directs the verification and quality control of reagents and control materials
utilised in procedures. Maintains reference standards and other materials
necessary for future assay evaluation.

Develop a technologist/technician training and/or cross-training and review
plan.

Assists Client Services department as required by receiving technical calls
from clients and sales staff.

Hires, evaluates and counsels staff required. Evaluates Human Resource
staffing needs and consults with Human Resources department to maintain
sufficient staff within the laboratory.

Ensures laboratory compliance with College of American Pathologists
(CAP) regulations

Lead the development of an external quality assessment scheme or an
equivalent association in conjunction with SLA and Specialty staff.

Provide QC review for the Diagnostic Manufacturing Division of Specialty.

Obtain CAP accreditation and IEC/ISO G25 for the laboratory 1998.
Sales And Marketing

Coordinate the development of the Clinical Trials Business of Specialty.

Oversee the development of technical/scientific seminars in conjunction with
Sales and Marketing for presentation by the Sales Team along the lines of the
Specialty Speaker’s Bureau with the focus on the introduction of new
technologists to Malaysia : Flow Cytometry, IHC, Image Analysis, PCR and
bDNA.

Provide direct sales and marketing support in the field with Specialty
Technical Sales Executives in the closure of laboratory services agreements
with hospitals, clinics and laboratories in Malaysia and Singapore.

Prepare and implement a schedule of Seminars to be given by Senior
Scientific and or technical staff in Malaysia.

Participate in the presentation of proposals in the major private hospitals as
needed by the Sales Team.
23

Assist in melding a cohesive management team in Specialty for both
laboratory , sales
and marketing.
24